INVA CIK: 1080014

Innoviva, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.31
FY22:
0.44
FY23:
0.34
FY24:
0.55
FY25:
0.73
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.61
FY22:
0.79
FY23:
0.90
FY24:
0.75
FY25:
0.91
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.93
FY22:
1.23
FY23:
1.24
FY24:
1.30
FY25:
1.64

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.13
FY23:
0.04
FY24:
0.24
FY25:
0.05
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.39
FY22:
0.53
FY23:
0.53
FY24:
0.37
FY25:
0.41
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.41
FY22:
0.57
FY23:
0.67
FY24:
0.69
FY25:
1.17
Total liabilities & equity
Change from FY22 to FY25
billions USD
FY21:
–
FY22:
1.23
FY23:
1.24
FY24:
1.30
FY25:
1.64

All amounts in billions USD Data sources:SEC EDGARTwelve Data